NCT04114682Active, not recruiting
Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 1 Dec 2025
Brief summary (registry, in English)
MODIFY study is a multi-centre prospective, longitudinal, observational cohort study which aims to recruit 150 adult patients with type 2 diabetes recruited from community, primary care or secondary care settings. The total length of the study is 75 months. The aim of the study is to develop an MRI-based method to identify whom amongst people with Type 2 diabetes are at risk of further complications in their kidney, liver and cardiovascular system.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 135 (actual)
- First submitted
- 1 Oct 2019
- Start date
- 27 Jan 2020
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Perspectum
- Diseases
- Type 2 diabetes
- NCT number
- NCT04114682
What you commit to
- Study type: Observational
- Participants enrolled: 135
- From 27 Jan 2020 to the primary completion date, 31 Mar 2025
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with known autoimmune hepatitis, viral hepatitis, Wilson's disease, haemoglobinopathies or significant structural renal tract abnormality.
- Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study.
Other
- The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MR exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia).
- Patients with known excessive alcohol intake.
Who the study is looking for
- Male or female over 18 years of age and diagnosed with type 2 diabetes.
- Participant currently taking glucose lowering therapy.
- Participant willing and able to give informed consent for participation in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aintree University Hospital NHS Foundation Trust Coordinator of this site? Confirm its status | Liverpool | United Kingdom | Unknown status |
| Royal Free Hospital NHS Foundation Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Perspectum Ltd. Coordinator of this site? Confirm its status | Oxford | United Kingdom | Unknown status |
| Oxford University Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | Oxford | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.